FindTrial
Sign In

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00548301
Enrollment
Unknown
Registered
2007-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2011-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndromes

Brief summary

The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.

Interventions

DRUGcyclosporine

Sponsors

Sirion Therapeutics, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Diagnosis of moderate to severe dry eye syndrome with or without Sjogren's syndrome or other autoimmune disease

Exclusion criteria

* Intraocular or refractive surgery in the study eye within 3 months prior to study start * Unwilling to discontinue use of contact lenses during the run-in and duration of the study * Pregnancy or lactation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026